Global Tinea Pedis Treatment Market 2017-2021

Overview of the global tinea pedis treatment market

Market research analysts at Technavio predict that the global tinea pedis treatment market will grow at a CAGR of more than 3% by 2021. This market research analysis identifies the rising prevalence of diabetes that is fueling the incidence of tinea pedis as one of the primary growth factors for this market. There is an increased prevalence of diabetes across the globe due to high levels of sugar in the bloodstreams and this results in numerous health issues.

Diabetes reduces the quality of life, increases the risk of obesity, and early death. People with diabetes tend to be more resistant to antifungal treatment regimens due to high blood glucose levels which increases the chances of fungal growth. Consequently, diabetes patients tend to have a high risk of foot ulcerations and infections that can lead to tinea pedis or onychomycosis resulting in the need for the effective treatment of this infection.

Get A Free Sample 

Tinea pedis treatment market trends

The growing instances of infectious diseases are influencing various government and non-government organizations to invest in R&D activities to develop antifungal drugs by providing the required funding to research institutes and companies. The provision of new incentives for the development of novel drugs and biologics influence various organizations to provide funding for the development of novel antifungal drugs. Funding also enables vendors to develop drugs without being limited by funds and also encourages the research institutes and companies to invest more in antifungal drug research. According to this market research report, the increased funding for antifungal research will be one of the key trends that will gain traction it the tinea pedis treatment market in the coming years.

Tinea pedis treatment market: Competitive landscape and key vendors

The market is highly competitive and fragmented due to the presence of several established international and regional key vendors. The vendors compete based on factors such as aggressive pricing and new indications. Vendors are increasing their market shares through M&A and distribution partnerships and are also investing in R&D for more antifungal research towards developing cost-effective innovative drugs to enter the emerging economies.

The leading vendors in the tinea pedis treatment market

• GSK
• Exeltis USA
• Valeant
• Viamet Pharmaceuticals

Tinea pedis treatment market segmentation by route of administration (ROA) 

• Oral
• Topical

The oral administration of drugs is the most effective method of treating tinea pedis and the drugs. There are numerous drugs created specifically for various ailments such as oral antimycotics and are used to treat chronic hyperkeratotic or inflammatory/vesicular tinea pedis.

Tinea pedis treatment market segmentation by disease type

• Interdigital
• Vesicular

The interdigital segment will account for the major shares of the tinea pedis treatment market throughout the forecast period. Interdigital tinea pedis is clinically characterized by scaling, maceration, and itching of the skin and there are a number of drugs available of the treatment of the disease. The wide prevalence of diabetes will be a major factor contributing to the growth of this market segment.

Want a bigger picture? Try a FREE sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.   

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global tinea pedis treatment market?
• What are the key market trends impacting the growth of the global tinea pedis treatment market?
• What are the challenges to market growth?
• Who are the key vendors in the global tinea pedis treatment market?
• What are the market opportunities and threats faced by the vendors in the global tinea pedis treatment market?
• Trending factors influencing the market shares of the Americas, APAC, and EMEA.
• What are the key outcomes of the five forces analysis of the global tinea pedis treatment market?

Technavio also offers customization on reports based on specific client requirement.